These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6639260)

  • 1. Use of heparin in the continuous flow centrifuge (CFC) during cytapheresis and plasmapheresis.
    Morales-Polanco MR; Pizzuto-Chávez J; Ambríz-Fernández R; Avilés-Miranda A; Sinco-Angeles A
    Arch Invest Med (Mex); 1983; 14(2):93-105. PubMed ID: 6639260
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of heparin for cytapheresis and plasmapheresis in a continuous flow centrifuge.
    Morales M; Pizzuto J; Reyna M; Ambriz R; Avilés A; Conte G; Sinco A
    Transfusion; 1982; 22(5):384-7. PubMed ID: 7123634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood purification therapy of systemic lupus erythematosus].
    Funauchi M; Horiuchi A
    Nihon Rinsho; 1992 Jan; 50 Suppl():317-22. PubMed ID: 1578701
    [No Abstract]   [Full Text] [Related]  

  • 4. Concomitant plasmapheresis and cladribine infusion for the treatment of life-threatening systemic lupus erythematosus.
    Delacruz WP; Cap A; Shumway N
    Intern Med J; 2016 Nov; 46(11):1345-1346. PubMed ID: 27813351
    [No Abstract]   [Full Text] [Related]  

  • 5. Fulminant lupus pneumonitis with acute renal failure and RBC aplasia. Successful management with plasmapheresis and immunosuppression.
    Isbister JP; Ralston M; Hayes JM; Wright R
    Arch Intern Med; 1981 Jul; 141(8):1081-3. PubMed ID: 7247596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmapheresis and cytapheresis.
    Nosé Y; Gurland HJ; Klein HG; Malchesky PS; Ota K
    Trans Am Soc Artif Intern Organs; 1982; 28():631-8. PubMed ID: 7164316
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recurrent lupus nephritis during pregnancy successfully treated by heparin and high dose intravenous gamma-globulin].
    Ito M; Ida E; Honda Y; Matsui K; Maeyama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2157-60. PubMed ID: 4078418
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma exchange in the treatment of aplastic anemia.
    Abdou NI
    Prog Clin Biol Res; 1982; 106():337-46. PubMed ID: 7178140
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic plasmapheresis by continuous flow cnetrifugation.
    Blacklock HA; Hill RS; Bridle M; Simpson IJ; Matthews JR; Woodfield DG
    N Z Med J; 1980 Aug; 92(666):145-8. PubMed ID: 6933347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic plasmapheresis in the combined therapy of systemic lupus erythematosus (a case report)].
    Kalinin NN; Pashinin AN; Alekberova ZS; Folomeev MIu; Kliukvina NG
    Ter Arkh; 1993; 65(7):85-6. PubMed ID: 8211790
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic applications of hemapheresis].
    Huestis DW; Pineda AA
    Sangre (Barc); 1982; 27(6):1059-72. PubMed ID: 6764036
    [No Abstract]   [Full Text] [Related]  

  • 12. [Problems in blood donors in plasmapheresis and cytopheresis].
    Fiala J
    Vnitr Lek; 1982 Feb; 28(2):182-8. PubMed ID: 7064373
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood-sampling strategy for monitoring continuous intravenous heparin therapy.
    Chenella FC; Klotz TA; Gill MA; Paulson YJ; Noguchi JK; Hurst AK; Robinson DC; Hill-Besinque K; Clifford CM; McGehee WG
    Clin Pharm; 1986 Jun; 5(6):510-3. PubMed ID: 3720219
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plasmosorption in the treatment of cold urticaria and systemic lupus erythematosus (a preliminary report)].
    Molodenkov MN; Lopukhin IuM; Evseev NG; Shurkalin BK; Ageev SL
    Vestn Dermatol Venerol; 1979 Aug; (8):58-60. PubMed ID: 494747
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of hematopoiesis by a plasma factor in a case of aplastic anemia associated with systemic lupus erythematosus.
    Marqués JA; Rhim H; Distenfeld A
    P R Health Sci J; 1995 Dec; 14(4):293-6. PubMed ID: 8637971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methods of plasmapheresis using blood fractionation devices].
    Kalinin NN
    Sov Med; 1989; (8):40-5. PubMed ID: 2683140
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lymphocytopheresis and plasmapheresis in rheumatoid arthritis].
    Dubrovina NA; Kalinin NN; Khotinian RI; Molchanova NP; Petrov MM
    Revmatologiia (Mosk); 1984; (3):9-12. PubMed ID: 6390635
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cell-plasmapheresis--indications and risks].
    Heinrichs C; Blauärmel O
    Z Arztl Fortbild (Jena); 1980 May; 74(9):410-5. PubMed ID: 7434810
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of granulocyte and platelet collection by semicontinuous plasmapheresis equipment (Hemonetics model 30) on blood donors: with special reference to the effects of high molecular hydroxyethyl starch].
    Shimoyama M; Minato K; Kitahara T
    Rinsho Ketsueki; 1981 Oct; 22(10):1661-6. PubMed ID: 6174751
    [No Abstract]   [Full Text] [Related]  

  • 20. Lupus treated with plasmapheresis.
    Wong KL
    Arch Ophthalmol; 2007 Aug; 125(8):1142; author reply 1142. PubMed ID: 17698778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.